2 completed, 1 recruiting, 1 unknown, 1 withdrawn. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Glycogen Storage Disease Type VII: new trials by email Literature Review of Glycogen Storage Disease Type VII trials Research Report on Glycogen Storage Disease Type VII
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rare Glycogen Storage Diseases Natural History Study No intervention - Glycogen Storage Disease, GSD Type 0A | Recruiting | Duke University | 200 | 2024-12-23 | 2026-01-07 | |
| Biomarker for Glycogen Storage Diseases (BioGlycogen) Fructose Metabolism, Inborn Errors, Glycogen Storage Disease | Withdrawn | CENTOGENE GmbH Rostock | 2018-08-20 | 2023-02-13 | ||
| The Effect of Triheptanoin on Fatty Acid Oxidation and Exercise Tolerance in Patients With Glycogenoses Triheptanoin, Placebo Oil - Tarui Disease, Debrancher Deficiency | Phase 2 | Completed | Copenhagen University Hospital, Rigshospitalet | 3 | 2018-08-15 | 2024-02-22 |
| Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Sugar - Metabolism, Inborn Errors, Lipid Metabolism, Inborn Errors | Not applicable | Unknown | Copenhagen University Hospital, Rigshospitalet | 60 | 2016-01-01 | 2019-10-16 |
| Genetic and Family Studies of Inherited Muscle Diseases Dermatomyositis, Glycogen Storage Disease Type II | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1993-05-01 | 2008-03-05 |
Glycogen Storage Disease Type II (3) · Glycogen Storage Disease Type III (3) · Dimauro disease (2) · Glycogen Storage Disease (2) · Glycogen Storage Disease Type IV (2) · Glycogen Storage Disease Type V (2) · Glycogen Storage Disease XIII (2) · Carbohydrate Metabolism, Inborn Errors (1) · Carnitine palmitoyl transferase 2 deficiency (1) · Chanarin-Dorfman Syndrome (1) · Dermatomyositis (1) · Fructose Metabolism, Inborn Errors (1) · Glycogen Storage Disease Type I (1) · Glycogen Storage Disease Type IIb (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Muscular Disorders, Atrophic (5) · Muscular Dystrophies (5) · Musculoskeletal Diseases (5) · Nervous System Diseases (5) · Neuromuscular Diseases (5) · Nutritional and Metabolic Diseases (5) · Carbohydrate Metabolism, Inborn Errors (4) · Metabolic Diseases (4) · Metabolism, Inborn Errors (4) · Muscular Diseases (4) · Brain Diseases (3) · Brain Diseases, Metabolic (3) · Brain Diseases, Metabolic, Inborn (3)
Sugars (1) · tricaprylin (1) · triheptanoin (1)
Copenhagen University Hospital, Rigshospitalet (2) · CENTOGENE GmbH Rostock (1) · Duke University (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)
Denmark (2) · United States (2) · Germany (1) · India (1) · Sri Lanka (1)
Karen L Madsen, MD (1) · Peter Bauer, Prof. (1) · Priya Kishnani, M.D. (1)
PMID 12122118, PMID 12210323, PMID 1281472, PMID 15293280, PMID 15781190, PMID 1580445, PMID 16602102, PMID 16763895, PMID 16763896, PMID 17584774, PMID 1824792, PMID 18401027, PMID 18541798, PMID 18645163, PMID 18929906, PMID 19237700, PMID 20357282, PMID 20393176, PMID 20631546, PMID 20655781, PMID 2199596, PMID 2295969, PMID 23031366, PMID 23507172, PMID 24453079, PMID 25272951, PMID 25832663, PMID 26255073, PMID 26652229, PMID 28932990, PMID 30990523, PMID 31492716, PMID 3447177, PMID 5235982, PMID 7634753, PMID 8755644
2017 (1)